Delivery Order SPE2DB24D1104-SPE2DB25FYEP9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,468.22 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.40 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive procurement of a specialized pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing...
- The Defense Logistics Agency awarded a $44,134.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of TREMFYA 100 MG/ML syringes. The contract, which is scheduled for completion by July 21, 2025, represents a competitively awarded purchase with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a primary pharmaceutical...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $29,825.39 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on September 15, 2025, with an ultimate completion date of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,786.40 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML syringes, with a completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, executed as a competitive award. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $19,006 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical products on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive award is performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYEP9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $42,826.81 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order for TREMFYA—a prescription medication used in dermatological applications—exemplifies the company's role in fulfilling specialized pharmaceutical needs within the military healthcare supply chain through the DLA's flexible pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.8k | 8/14/25 |